[Skip to Content]
[Skip to Content Landing]
Views 1,706
Citations 0
From The Medical Letter on Drugs and Therapeutics
July 14, 2020

Peanut Allergen Powder (Palforzia)

JAMA. 2020;324(2):192-193. doi:10.1001/jama.2020.3599

The FDA has approved peanut allergen powder-dnfp (Palforzia – Aimmune) for use as oral immunotherapy to mitigate allergic reactions, including anaphylaxis, caused by accidental peanut exposure in patients with a confirmed peanut allergy (Box). It is the first drug to be approved in the US for this indication; Viaskin Peanut, an immunotherapy patch, is under FDA review for the same indication.